150 related articles for article (PubMed ID: 8088177)
21. III. Instantaneous inhibition by compound 48/80 of tissue factor-initiated extrinsic coagulation is mediated by the downregulation of factor VII activation.
Chu AJ; Wang ZG; Fox MJ
Arch Biochem Biophys; 2000 May; 377(2):357-65. PubMed ID: 10845714
[TBL] [Abstract][Full Text] [Related]
22. Phospholipid surfaces regulate the delivery of substrate to tissue factor:VIIa and the removal of product.
Hathcock JJ; Rusinova E; Andree H; Nemerson Y
Blood Cells Mol Dis; 2006; 36(2):194-8. PubMed ID: 16529959
[TBL] [Abstract][Full Text] [Related]
23. In situ analysis of tissue factor-dependent thrombin generation in human atherosclerotic vessels.
Westmuckett AD; Lupu C; Goulding DA; Das S; Kakkar VV; Lupu F
Thromb Haemost; 2000 Nov; 84(5):904-11. PubMed ID: 11127875
[TBL] [Abstract][Full Text] [Related]
24. Functional analysis of the factor IX epidermal growth factor-like domain mutation Ile66Thr associated with mild hemophilia B.
Knobe KE; Persson KE; Sjörin E; Villoutreix BO; Ljung RC
Pathophysiol Haemost Thromb; 2006; 35(5):370-5. PubMed ID: 17230038
[TBL] [Abstract][Full Text] [Related]
25. [Inactivated factor VII exercises a powerful antithrombotic activity in an experimental model of recurrent arterial thrombosis].
Ragni M; Golino P; Cirillo P; Pascucci I; Scognamiglio A; Ravera A; Esposito N; Battaglia C; Guarino A; Chiariello M
Cardiologia; 1996 Jan; 41(1):51-8. PubMed ID: 8697470
[TBL] [Abstract][Full Text] [Related]
26. The tissue factor/factor VIIa/factor Xa complex: a model built by docking and site-directed mutagenesis.
Norledge BV; Petrovan RJ; Ruf W; Olson AJ
Proteins; 2003 Nov; 53(3):640-8. PubMed ID: 14579355
[TBL] [Abstract][Full Text] [Related]
27. Biological control of factor VII.
Nemerson Y
Thromb Haemost; 1976 Feb; 35(1):96-100. PubMed ID: 989197
[TBL] [Abstract][Full Text] [Related]
28. Administration of granulocyte-colony-stimulating factor for allogeneic hematopoietic cell collection may induce the tissue factor-dependent pathway in healthy donors.
Topcuoglu P; Arat M; Dalva K; Ozcan M
Bone Marrow Transplant; 2004 Jan; 33(2):171-6. PubMed ID: 14647251
[TBL] [Abstract][Full Text] [Related]
29. The effect of O-fucosylation on the first EGF-like domain from human blood coagulation factor VII.
Kao YH; Lee GF; Wang Y; Starovasnik MA; Kelley RF; Spellman MW; Lerner L
Biochemistry; 1999 Jun; 38(22):7097-110. PubMed ID: 10353820
[TBL] [Abstract][Full Text] [Related]
30. Coagulation factor IX residues G4-Q11 mediate its interaction with a shared factor IX/IXa binding site on activated platelets but not the assembly of the functional factor X activating complex.
Ahmad SS; Wong MY; Rawala R; Jameson BA; Walsh PN
Biochemistry; 1998 Feb; 37(6):1671-9. PubMed ID: 9484238
[TBL] [Abstract][Full Text] [Related]
31. Activated factor VII activates factors IX and X on the surface of activated platelets: thoughts on the mechanism of action of high-dose activated factor VII.
Hoffman M; Monroe DM; Roberts HR
Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S61-5. PubMed ID: 9819030
[TBL] [Abstract][Full Text] [Related]
32. Impaired human tissue factor-mediated activity in blood clotting factor VIINagoya (Arg304-->Trp). Evidence that a region in the catalytic domain of factor VII is important for the association with tissue factor.
Matsushita T; Kojima T; Emi N; Takahashi I; Saito H
J Biol Chem; 1994 Mar; 269(10):7355-63. PubMed ID: 8125953
[TBL] [Abstract][Full Text] [Related]
33. Factor IX of the blood coagulation system: a review.
Taran LD
Biochemistry (Mosc); 1997 Jul; 62(7):685-93. PubMed ID: 9331959
[TBL] [Abstract][Full Text] [Related]
34. Two independent binding sites on monolayers of human endothelial cells are responsible for interaction with coagulation factor VII and factor VIIa.
Reuning U; Preissner KT; Müller-Berghaus G
Thromb Haemost; 1993 Feb; 69(2):197-204. PubMed ID: 8456434
[TBL] [Abstract][Full Text] [Related]
35. Characterization of recombinant murine factor VIIa and recombinant murine tissue factor: a human-murine species compatibility study.
Petersen LC; Nørby PL; Branner S; Sørensen BB; Elm T; Stennicke HR; Persson E; Bjørn SE
Thromb Res; 2005; 116(1):75-85. PubMed ID: 15850611
[TBL] [Abstract][Full Text] [Related]
36. Activation of cancer cell migration and invasion by ectopic synthesis of coagulation factor VII.
Koizume S; Jin MS; Miyagi E; Hirahara F; Nakamura Y; Piao JH; Asai A; Yoshida A; Tsuchiya E; Ruf W; Miyagi Y
Cancer Res; 2006 Oct; 66(19):9453-60. PubMed ID: 17018600
[TBL] [Abstract][Full Text] [Related]
37. Solution structure of the N-terminal EGF-like domain from human factor VII.
Muranyi A; Finn BE; Gippert GP; Forsén S; Stenflo J; Drakenberg T
Biochemistry; 1998 Jul; 37(30):10605-15. PubMed ID: 9692950
[TBL] [Abstract][Full Text] [Related]
38. A cyclic pentapeptide derived from the second EGF-like domain of Factor VII is an inhibitor of tissue factor dependent coagulation and thrombus formation.
Orning L; Fischer PM; Hu CK; Agner E; Engebretsen M; Husbyn M; Petersen LB; Orvim U; Llinas M; Sakariassen KS
Thromb Haemost; 2002 Jan; 87(1):13-21. PubMed ID: 11848442
[TBL] [Abstract][Full Text] [Related]
39. Synthetic peptide analogs of tissue factor and factor VII which inhibit factor Xa formation by the tissue factor/factor VIIa complex.
Rønning HF; Risøen UC; Orning L; Sletten K; Sakariassen KS
Thromb Res; 1996 Oct; 84(2):73-81. PubMed ID: 8897697
[TBL] [Abstract][Full Text] [Related]
40. Characterization of a homozygous Gly11Val mutation in the Gla domain of coagulation factor X.
Chafa O; Tagzirt M; Tapon-Bretaudière J; Reghis A; Fischer AM; LeBonniec BF
Thromb Res; 2009 May; 124(1):144-8. PubMed ID: 19135706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
